Clinical trials
Memory clinical trials
Below are recruiting memory clinical trials, each written for real people, not researchers. We’re tracking 969 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT01775072Recruiting
Genetic testing using stored or new cancer samples
This study collects and analyzes genetic information from tissue or blood samples to help understand cancer and related inherited (family) risk. It may involve testing results being shared with you or your care team, depending on what samples are available.
Bridgeport, ConnecticutAges Any age - NCT00588185Recruiting
PET scans to track prostate cancer using two tracers
This trial uses special PET imaging to see where progressive prostate cancer is in the body—one tracer to look at general sugar use and one designed to detect testosterone-related activity. It may help doctors better map cancer spread so future treatment planning can be more targeted.
Basking Ridge, New JerseyAges Any age - NCT02087852Recruiting
Kidney cancer DNA registry for patients and family
This study collects DNA from adults with kidney cancer (or suspected kidney cancer), plus DNA from some family members and healthy controls. It helps researchers understand whether certain genetic changes might be linked to kidney cancer risk.
Basking Ridge, New JerseyAges 18 years+ - NCT02099734Recruiting
DNA registry for germ cell and testicular tumors
This study collects DNA and medical information to better understand germ cell and testicular tumors and possible inherited genetic causes. It may help researchers sort out how genetic changes relate to these cancers, even if you’re not receiving a new drug.
Basking Ridge, New JerseyAges 18 years+ - NCT07399977Recruiting
Blood test to guide blood thinner use in cancer
This study tests whether a blood test and computer program can help doctors decide how long you need to take blood thinners after a cancer-related blood clot. If you've been on a blood thinner for a few months and have certain cancers, this trial may offer a more personalized approach.
Basking Ridge, New JerseyAges 18 years+ - NCT07400523RecruitingPhase 3
Ribociclib for breast cancer with leftover disease after chemo
This trial tests ribociclib, a targeted therapy, for women with hormone receptor-positive, HER2-negative breast cancer who still have cancer cells in the breast or lymph nodes after initial chemotherapy. It aims to reduce the chance of cancer coming back.
Zhanjiang, GuangdongAges 18 years+ - NCT07400809Recruiting
Cervical cancer with limited spread: a study on treatment results
This study looks at women with cervical cancer that has spread to only a few places (oligo-metastatic) or come back in a few places (oligo-recurrent). It hopes to understand how well treating those spots with radiation or other local treatments works, even if you've already had treatment before.
Mumbai, MaharashtraAges Any age - NCT07401537RecruitingPhase 2
Comparing two schedules of immunotherapy for advanced triple-negative breast cancer
This trial tests whether giving immunotherapy less often (extended dose intervals) works as well as the standard schedule for people with advanced triple-negative breast cancer who have already completed 6 cycles of first-line treatment. It aims to see if a longer break between doses can be just as effective with fewer hospital visits.
Guangzhou, GuangdongAges 18–70 - NCT07401641Recruiting
Pain control study for oral cancer surgery
This study tests two different pain medicines (dezocine or nalbuphine) combined with sufentanil to see which helps better control pain after oral cancer surgery with free flap reconstruction. It also looks at side effects and how well the transplanted tissue survives.
Guangzhou, GuangdongAges 18–70 - NCT07404176RecruitingPhase 2
New radioactive drug for advanced neuroendocrine tumors
This trial tests a new radioactive drug, Terbium-161 DOTATATE, for people with advanced neuroendocrine tumors that have stopped responding to a similar treatment called Lu-177 DOTATATE. It aims to see if this new drug is safe and can help shrink tumors.
Mumbai, MaharashtraAges 18–70 - NCT07420777Recruiting
3D-printed aligners for treating an open bite
This study tests whether new 3D-printed shape-memory aligners can effectively fix a mild-to-moderate open bite (when front teeth don't touch when you bite down). It may be a good option if you are between 18 and 35, generally healthy, and have a mild open bite with fairly straight teeth.
Erbil, Erbil GovernorateAges 18–35 - NCT07428044RecruitingPhase 2
Trastuzumab Deruxtecan for HER2-mutant lung cancer before surgery
This trial tests a targeted drug, trastuzumab deruxtecan, for people with non-small cell lung cancer that has a specific HER2 gene change. The treatment is given before surgery to shrink the tumor and make it easier to remove.
Ann Arbor, MichiganAges 18 years+ - NCT07431710Recruiting
AI-guided chest compressions for cardiac arrest in the ER
This trial tests whether artificial intelligence (AI) can help doctors give better chest compressions during CPR for adults whose hearts stopped outside the hospital. The goal is to improve blood flow and outcomes without using special equipment in the ambulance.
New Taipei City, BanqiaoAges 20 years+ - NCT07435623Recruiting
Long-term side effects of radiation for cervical and endometrial cancers
This study looks at late side effects in patients who had radiation therapy after surgery for cervical or endometrial cancer. Understanding these effects can help improve future care.
Mumbai, MaharashtraAges 18–75 - NCT07440017Recruiting
Aging and memory study: How older adults learn
This study uses brain scans to understand how older adults (65-80) and younger adults (18-30) learn and generalize information. It may help explain memory changes with age.
Milwaukee, WisconsinAges 18–80 - NCT07447856RecruitingPhase 1
Herbal plasters for pain relief while using opioids
This trial tests a topical herbal plaster to see if it can help reduce pain in people with cancer who are already taking opioids. The plaster is placed on the most painful area and may allow you to use less opioid medication.
Basking Ridge, New JerseyAges 18 years+ - NCT07449195Recruiting
Comparing two eye-imaging devices for eye tumors
This study compares two non-invasive imaging machines (OCT) that take detailed pictures of eye tumors. The goal is to see which machine gives better images, helping doctors choose the best tool for diagnosing and monitoring eye tumors.
Basking Ridge, New JerseyAges 18 years+ - NCT07454330Recruiting
Support program for Chinese cancer patients' quality of life
This trial tests a support program designed to improve quality of life for Chinese cancer patients and survivors. If you qualify, you'll join the program by phone or video call.
Basking Ridge, New JerseyAges 18 years+ - NCT07454382RecruitingPhase 2
Study of elranatamab and cyclophosphamide for multiple myeloma
This trial studies a new medicine called elranatamab combined with the chemotherapy drug cyclophosphamide for people with multiple myeloma that has returned or not responded to prior treatments. It may be a good option if you have aggressive or high-risk myeloma.
Basking Ridge, New JerseyAges 18 years+ - NCT07459673RecruitingPhase 2
HER2-positive breast cancer trial using ctDNA to guide treatment
This trial tests a personalized treatment plan for HER2-positive breast cancer that has spread. It uses a blood test to track cancer DNA and adjust therapy, including treatments that may help prevent cancer from reaching the brain. The goal is to achieve long-term remission.
Basking Ridge, New JerseyAges 18 years+ - NCT07466290Recruiting
L-serine with strength training for seniors
This trial tests whether taking a supplement called L-serine along with a strength training program can improve muscle strength and function in older adults. It might help you stay strong and independent.
Vienna, State of ViennaAges 65–85 - NCT07472881Recruiting
Laser therapy for body shape in obese menopausal women
This study tests whether a laser therapy applied to specific points on the body can help with weight and body shape in women going through menopause who are overweight. It aims to find a safe, non-invasive option for weight management.
Keelung, TaiwanAges 45–55 - NCT07477457RecruitingPhase 2
Targeted drugs plus chemo for advanced osteosarcoma
This trial combines four targeted drugs (gefitinib, trametinib, disulfiram, sunitinib) with standard chemotherapy to treat osteosarcoma that has spread or come back. The goal is to see if this drug mix helps shrink tumors or keep them from growing.
Basking Ridge, New JerseyAges 6–49 - NCT07483307RecruitingPhase 2
Hormone therapy before surgery for lobular breast cancer
This trial tests whether taking hormone therapy before surgery can improve outcomes for women with a specific type of breast cancer called lobular breast cancer. If you qualify, you would receive endocrine therapy for 6 months before your planned breast-conserving surgery.
Basking Ridge, New JerseyAges 50 years+
Hear when a new Memory trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for memory?
- Yes. Clin2 currently lists 969 recruiting memory studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a memory trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a memory trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.